Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis oc…

Continue in Briflio to read, react, comment, and share.